Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-24-003035
Filing Date
2024-12-31
Accepted
2024-12-31 16:05:19
Documents
2
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT eh240570086_3-brennan.html 3  
1 OWNERSHIP DOCUMENT eh240570086_3-brennan.xml 3 6279
2 EXHIBIT 24.1 eh240570086_ex2401.htm EX-24.1 7214
  Complete submission text file 0000950142-24-003035.txt   14965
Mailing Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4
Business Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4 (732) 300-3046
Medicus Pharma Ltd. (Issuer) CIK: 0001997296 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 KING ST W SUITE 3400 TORONTO Z4 M5X 1A4
Business Address
Brennan Edward J. (Reporting) CIK: 0002048104 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42408 | Film No.: 241593025